Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154272211> ?p ?o ?g. }
- W3154272211 endingPage "2273" @default.
- W3154272211 startingPage "2273" @default.
- W3154272211 abstract "Novel 6-bromo-coumarin-ethylidene-hydrazonyl-thiazolyl and 6-bromo-coumarin-thiazolyl-based derivatives were synthesized. A quantitative structure activity relationship (QSAR) model with high predictive power r2 = 0.92, and RMSE = 0.44 predicted five compounds; 2b, 3b, 5a, 9a and 9i to have potential anticancer activities. Compound 2b achieved the best ΔG of –15.34 kcal/mol with an affinity of 40.05 pki. In a molecular dynamic study 2b showed an equilibrium at 0.8 Å after 3.5 ns, while flavopiridol did so at 0.5 Å after the same time (3.5 ns). 2b showed an IC50 of 0.0136 µM, 0.015 µM, and 0.054 µM against MCF-7, A-549, and CHO-K1 cell lines, respectively. The CDK4 enzyme assay revealed the significant CDK4 inhibitory activity of compound 2b with IC50 of 0.036 µM. The selectivity of the newly discovered lead compound 2b toward localization in tumor cells was confirmed by a radioiodination biological assay that was done via electrophilic substitution reaction utilizing the oxidative effect of chloramine-t. 131I-2b showed good in vitro stability up to 4 h. In solid tumor bearing mice, the values of tumor uptake reached a height of 5.97 ± 0.82%ID/g at 60 min p.i. 131I-2b can be considered as a selective radiotheranostic agent for solid tumors with promising anticancer activity." @default.
- W3154272211 created "2021-04-26" @default.
- W3154272211 creator A5025603395 @default.
- W3154272211 creator A5025675807 @default.
- W3154272211 creator A5028147009 @default.
- W3154272211 creator A5069528359 @default.
- W3154272211 creator A5088164112 @default.
- W3154272211 creator A5089347460 @default.
- W3154272211 date "2021-04-14" @default.
- W3154272211 modified "2023-09-27" @default.
- W3154272211 title "Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D QSAR, Molecular Dynamics, In Vitro Cytotoxicity, Radioiodination, and Biodistribution Studies" @default.
- W3154272211 cites W1641019653 @default.
- W3154272211 cites W1984264526 @default.
- W3154272211 cites W1984440042 @default.
- W3154272211 cites W1985389450 @default.
- W3154272211 cites W2000590884 @default.
- W3154272211 cites W2012883056 @default.
- W3154272211 cites W2016552601 @default.
- W3154272211 cites W2020681885 @default.
- W3154272211 cites W2021426023 @default.
- W3154272211 cites W2046024621 @default.
- W3154272211 cites W2057272791 @default.
- W3154272211 cites W2066786160 @default.
- W3154272211 cites W2080854649 @default.
- W3154272211 cites W2096979580 @default.
- W3154272211 cites W2097144166 @default.
- W3154272211 cites W2110793625 @default.
- W3154272211 cites W2114918609 @default.
- W3154272211 cites W2126216101 @default.
- W3154272211 cites W2133382697 @default.
- W3154272211 cites W2135129680 @default.
- W3154272211 cites W2140642045 @default.
- W3154272211 cites W2143238584 @default.
- W3154272211 cites W2148345265 @default.
- W3154272211 cites W2153389501 @default.
- W3154272211 cites W2171852242 @default.
- W3154272211 cites W2178607918 @default.
- W3154272211 cites W2219817965 @default.
- W3154272211 cites W2315860036 @default.
- W3154272211 cites W2318725321 @default.
- W3154272211 cites W2464034369 @default.
- W3154272211 cites W2475360018 @default.
- W3154272211 cites W2593242170 @default.
- W3154272211 cites W2600104229 @default.
- W3154272211 cites W2623967024 @default.
- W3154272211 cites W2742910022 @default.
- W3154272211 cites W2744255174 @default.
- W3154272211 cites W2751240609 @default.
- W3154272211 cites W2802098834 @default.
- W3154272211 cites W2805527526 @default.
- W3154272211 cites W2883416993 @default.
- W3154272211 cites W2885203907 @default.
- W3154272211 cites W2892328684 @default.
- W3154272211 cites W2909349197 @default.
- W3154272211 cites W2910406071 @default.
- W3154272211 cites W2945156880 @default.
- W3154272211 cites W2964830680 @default.
- W3154272211 cites W2966465764 @default.
- W3154272211 cites W2970349558 @default.
- W3154272211 cites W2972484391 @default.
- W3154272211 cites W2978637795 @default.
- W3154272211 cites W2991551391 @default.
- W3154272211 cites W2997502398 @default.
- W3154272211 cites W3001990253 @default.
- W3154272211 cites W3010714596 @default.
- W3154272211 cites W3011543462 @default.
- W3154272211 cites W3018056821 @default.
- W3154272211 cites W3029225363 @default.
- W3154272211 cites W3037436862 @default.
- W3154272211 cites W3043147262 @default.
- W3154272211 cites W3048028488 @default.
- W3154272211 cites W3094664617 @default.
- W3154272211 doi "https://doi.org/10.3390/molecules26082273" @default.
- W3154272211 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8070829" @default.
- W3154272211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33919867" @default.
- W3154272211 hasPublicationYear "2021" @default.
- W3154272211 type Work @default.
- W3154272211 sameAs 3154272211 @default.
- W3154272211 citedByCount "11" @default.
- W3154272211 countsByYear W31542722112022 @default.
- W3154272211 countsByYear W31542722112023 @default.
- W3154272211 crossrefType "journal-article" @default.
- W3154272211 hasAuthorship W3154272211A5025603395 @default.
- W3154272211 hasAuthorship W3154272211A5025675807 @default.
- W3154272211 hasAuthorship W3154272211A5028147009 @default.
- W3154272211 hasAuthorship W3154272211A5069528359 @default.
- W3154272211 hasAuthorship W3154272211A5088164112 @default.
- W3154272211 hasAuthorship W3154272211A5089347460 @default.
- W3154272211 hasBestOaLocation W31542722111 @default.
- W3154272211 hasConcept C109316439 @default.
- W3154272211 hasConcept C116569031 @default.
- W3154272211 hasConcept C118792377 @default.
- W3154272211 hasConcept C161790260 @default.
- W3154272211 hasConcept C164126121 @default.
- W3154272211 hasConcept C170493617 @default.
- W3154272211 hasConcept C178790620 @default.
- W3154272211 hasConcept C185592680 @default.
- W3154272211 hasConcept C202751555 @default.